Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization.

Jonathan FintziTyler BonnettDaniel A SweeneyNikhil A HuprikarAnuradha GanesanMaria G FrankSusan L F McLellanLori E DoddPablo TebasAneesh K Mehta

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

Remdesivir speeds time to recovery by preventing worsening to clinical states that would extend the course of hospitalization and increase intensive respiratory support, thereby reducing the overall demand for hospital care.

Keyphrases

healthcare
sars cov
coronavirus disease
palliative care
emergency department
phase iii
combination therapy
acute care
double blind
respiratory tract
phase ii